Unlock stock picks and a broker-level newsfeed that powers Wall Street.

LSE - Delayed Quote GBp

Shield Therapeutics plc (STX.L)

2.3500
+0.0900
+(3.98%)
At close: April 25 at 4:08:39 PM GMT+1
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
13,085
13,085
5,499
2,050.0985
14,155.6619
Cost of Revenue
9,058
9,058
3,041
1,322.6442
1,845.2649
Gross Profit
4,027
4,027
2,458
727.4543
12,310.3970
Operating Expense
35,358
35,358
34,104
28,116.9865
15,245.9217
Operating Income
-31,331
-31,331
-31,646
-27,389.5322
-2,935.5248
Net Non Operating Interest Income Expense
-501
-501
-442
6.7482
2.7256
Pretax Income
-32,375
-32,375
-49,343
-26,867.2227
-2,570.2877
Tax Provision
918
918
446
-309.0669
1,013.9417
Net Income Common Stockholders
-33,293
-33,293
-49,789
-26,558.1559
-3,584.2294
Diluted NI Available to Com Stockholders
-33,293
-33,293
-49,789
-26,558.1559
-3,584.2294
Basic EPS
-0.12
-0.05
-0.21
-0.12
-0.03
Diluted EPS
-0.12
-0.05
-0.21
-0.12
-0.03
Basic Average Shares
476,634.2460
665,860
237,905.8820
221,163.3980
120,682.0580
Diluted Average Shares
476,634.2460
665,860
237,905.8820
221,163.3980
120,682.0580
Total Operating Income as Reported
-31,331
-31,331
-49,752
-27,389.5322
-2,935.5248
Rent Expense Supplemental
--
--
147.6443
98.5235
65.4156
Total Expenses
44,416
44,416
37,145
29,439.6307
17,091.1866
Net Income from Continuing & Discontinued Operation
-33,293
-33,293
-49,789
-26,558.1559
-3,584.2294
Normalized Income
-33,293
-33,293
-35,123.1400
-26,558.1559
-3,584.2294
Interest Income
518
518
37
17.5453
4.0885
Interest Expense
1,016
1,016
403
--
--
Net Interest Income
-501
-501
-442
6.7482
2.7256
EBIT
-31,359
-31,359
-48,940
-26,867.2227
-2,570.2877
EBITDA
-30,288
-30,288
-46,067
-23,888.5740
1,116.1536
Reconciled Cost of Revenue
9,058
9,058
3,041
1,322.6442
1,845.2649
Reconciled Depreciation
1,071
1,071
2,662
2,978.6487
3,686.4413
Net Income from Continuing Operation Net Minority Interest
-33,293
-33,293
-49,789
-26,558.1559
-3,584.2294
Total Unusual Items Excluding Goodwill
--
--
-18,106
--
--
Total Unusual Items
--
--
-18,106
--
--
Normalized EBITDA
-30,288
-30,288
-27,961
-23,888.5740
1,116.1536
Tax Rate for Calcs
0.0002
0.0002
0.0002
0
0.0002
Tax Effect of Unusual Items
--
--
-3,440.1400
--
--
12/31/2020 - 2/26/2016

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

AEQ.F Aequus Pharmaceuticals Inc.
0.0005
0.00%
 
5SS0.F Simply Better Brands Corp.
0.5340
+3.49%
 
GENIL.IS Gen Ilac Ve Saglik Urunleri Sanayi Ve Ticaret Anonim Sirketi
121.30
+1.08%
 
GABA.ST Gabather AB (publ)
0.0396
-2.94%
 
VCBD Vitalibis, Inc.
0.0018
+28.57%
 
GHG.CN Global Hemp Group Inc.
0.0200
0.00%
 
KLAR.ST Klaria Pharma Holding AB (publ.)
1.1500
-3.77%
 
TGIF.CN 1933 Industries Inc.
0.0050
0.00%
 
4502.T Takeda Pharmaceutical Company Limited
4,275.00
+0.38%
 
CRNO-B.ST Cereno Scientific AB (publ)
8.00
+0.38%